Chenyue Xu, Xueping Huang, Ye Zong, Peng Li, Shutian Zhang, Haiyun Shi. Dual Targeted Therapy for Refractory Inflammatory Bowel Disease: A Systematic Review and Meta‐Analysis. // Journal of Evidence-Based Medicine. – 2026. – DOI: 10.1111/jebm.70157. – URL: https://onlinelibrary.wiley.com/doi/10.1111/jebm.70157?af=R
Chenyue Xu, Xueping Huang, Ye Zong, Peng Li, Shutian Zhang, & Haiyun Shi (2026). Dual Targeted Therapy for Refractory Inflammatory Bowel Disease: A Systematic Review and Meta‐Analysis. Journal of Evidence-Based Medicine. https://doi.org/10.1111/jebm.70157
Chenyue Xu, et al. “Dual Targeted Therapy for Refractory Inflammatory Bowel Disease: A Systematic Review and Meta‐Analysis.” Journal of Evidence-Based Medicine, 2026. doi:10.1111/jebm.70157.
@article{Xu2026,
title = {Dual Targeted Therapy for Refractory Inflammatory Bowel Disease: A Systematic Review and Meta‐Analysis},
author = {Xu, Chenyue and Huang, Xueping and Zong, Ye and Li, Peng and Zhang, Shutian and Shi, Haiyun},
journal = {Journal of Evidence-Based Medicine},
year = {2026},
doi = {10.1111/jebm.70157},
url = {https://onlinelibrary.wiley.com/doi/10.1111/jebm.70157?af=R}
}